Aveanna Healthcare Holdings Inc. Common Stock (AVAH) is a publicly traded Healthcare sector company. As of November 12, 2026, AVAH trades at $12.58 with a market cap of $2.88B and a P/E ratio of 11.03. AVAH moved -3.91% today. Year to date, AVAH is +59.34%; over the trailing twelve months it is +45.86%. Its 52-week range spans $3.73 to $14.71. Analyst consensus is buy with an average price target of $14.88. Rallies surfaces AVAH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Aveanna raises 2026 revenue and EBITDA guidance after Q3 growth: Aveanna Healthcare’s Q3 2026 revenue rose 12% year over year to $695.5 million, beating analyst estimates of $679.51 million, while net income was $45.5 million and adjusted EBITDA rose 25% to $100.1 million. It raised 2026 revenue guidance to greater than $2.695 billion and adjusted EBITDA guidance to greater than $374 million.
| Metric | Value |
|---|---|
| Price | $12.58 |
| Market Cap | $2.88B |
| P/E Ratio | 11.03 |
| EPS | $1.11 |
| Dividend Yield | 0.00% |
| 52-Week High | $14.71 |
| 52-Week Low | $3.73 |
| Volume | 6.85K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.43B |
| Net Income | $225.03M |
| Gross Margin | 33.31% |
9 analysts cover AVAH: 0 strong buy, 6 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $14.88.